KENNETH M. BOY

PET-IMAGING IMMUNOMODULATORS

PET-imaging immunomodulators

Immunomodulators

MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS

Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

Immunomodulators

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

Immunomodulators

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

Compounds for the reduction of β-amyloid production

Compounds for the reduction of beta-amyloid production

Compounds for the reduction of beta-amyloid production

Compounds for the reduction of β-amyloid production

Bicyclic compounds for the reduction of beta-amyloid production

Isophthalates as beta-secretase inhibitors

Substituted tetrahydroisoquinolines as β-secretase inhibitors

N-aryl pyrrolidine derivatives as beta-secretase inhibitors

2-aryl thiazole derivatives as KCNQ modulators

Isophthalates as beta-secretase inhibitors

Gamma-lactams as beta-secretase inhibitors

Aminoalkyl thiazole derivatives as KCNQ modulators

3-Thia-4-arylquinolin-2-one potassium channel modulators

Compounds for the treatment of male erectile dysfunction

3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants

Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus

3-thia-4-arylquinolin-2-one derivatives

3-thia-4-arylquinolin-2-one derivatives